The medtech sector is much changed from where it was a year or even six months ago, with some of the biggest names shifting to take a bigger share of the market and others moving out of it altogether, findings show in the EP Vantage Medtech Half-Year Review 2015.
Key highlights include:
The first half of 2015 saw 86 mergers and acquisitions in the medtech industry, but the figure for the total value of mergers closed is anything but average at a whopping $83 billion
Just $1.6bn was raised in venture funding in the first half, and while in the first half of 2014 there were three rounds of $100m-plus, this time no company has broken the $60m mark
The FDA granted either a first-time premarket approval or a humanitarian device exemption to 26 devices, compared with 33 during the whole of 2014, putting this year on track to see the most device approvals for a decade
Download your copy of the report: